Intravenous immunoglobulins: can the blood pressure response in laboratory animals be considered a predictive criterion for good clinical tolerance?
Having noted that the only physico-chemical and biological test recommended cannot ensure good tolerance of i.v. IgG in man, we studied a physiological test consisting of evaluating blood pressure during infusion in conscious dogs (10 mg/kg/min) or after i.v. injection in rats (250 mg/kg in 12 sec.). The data were obtained on more than 100 dogs and 500 rats. For preparations known to be well tolerated in man or inducing a few clinical intolerances, the correlation with hypotension in rats and dogs seems good. Therefore, we think this test has its place in the battery of i.v. IgG qualification tests carried out before passage to man. Institut Mérieux has developed a new intact i.v. IgG equilibrated in sub-classes, without PKA, low in IgA and not hypotensive in these two species.
D000818:Animals; D001794:Blood Pressure; D004285:Dogs; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007116:Immunization, Passive / Q000592:standards*; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000592:standards*; D007262:Infusions, Intravenous
D007074:Immunoglobulin G